Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Firefly Neuroscience (AIFF) EBIT (2016 - 2025)

Historic EBIT for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$2.7 million.

  • Firefly Neuroscience's EBIT rose 3776.94% to -$2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.8 million, marking a year-over-year decrease of 1962.13%. This contributed to the annual value of -$10.1 million for FY2024, which is 22664.07% down from last year.
  • Latest data reveals that Firefly Neuroscience reported EBIT of -$2.7 million as of Q3 2025, which was up 3776.94% from -$1.6 million recorded in Q2 2025.
  • Firefly Neuroscience's EBIT's 5-year high stood at $493116.0 during Q2 2023, with a 5-year trough of -$4.3 million in Q3 2024.
  • For the 5-year period, Firefly Neuroscience's EBIT averaged around -$1.4 million, with its median value being -$1.3 million (2024).
  • As far as peak fluctuations go, Firefly Neuroscience's EBIT soared by 31070.16% in 2021, and later tumbled by 306276.33% in 2022.
  • Firefly Neuroscience's EBIT (Quarter) stood at -$2.9 million in 2021, then surged by 64.67% to -$1.0 million in 2022, then crashed by 54.76% to -$1.6 million in 2023, then crashed by 119.27% to -$3.4 million in 2024, then rose by 22.7% to -$2.7 million in 2025.
  • Its last three reported values are -$2.7 million in Q3 2025, -$1.6 million for Q2 2025, and -$2.1 million during Q1 2025.